PharmEasy parent API Holdings pulls IPO, pivots to rights issue for growth funding
API Holdings withdrew its DRHP filed November 9, 2021, citing adverse market conditions. The online pharmacy parent now plans a rights issue opening early September 2022 to fund expansion, signaling continued capital strain across digital health retail.
What happened
API Holdings, parent of online pharmacy PharmEasy, withdrew its IPO DRHP citing market conditions, and plans a rights issue opening early September 2022 to fund
Key facts
- November 9, 2021
- 30-day period
- September 2022
Why this matters
Capital-strained online pharmacy assets like PharmEasy may become open to strategic partnerships or acqui-hire conversations as private funding gets pricier.